Abstract
Cardiac and vascular biomarkers are used in the diagnosis, assessment, and prognosis of a variety of cardiovascular diseases in adults and children. For children, cardiac biomarkers are most often used to assess cardiomyopathy or congenital cardiovascular malformations or for monitoring during cardio-pulmonary bypass and pre- and post-heart transplantation. Because the risk for cardiovascular events in adulthood can be tracked from childhood, interest is high in identifying biomarkers of vascular inflammation in children that might also predict atherosclerotic events later in life. Here, we review the most common and promising biomarkers and comment on their current and potential uses in monitoring and predicting cardiovascular dysfunction.
| Original language | English |
|---|---|
| Pages (from-to) | 25-34 |
| Number of pages | 10 |
| Journal | Progress in Pediatric Cardiology |
| Volume | 32 |
| Issue number | 1 |
| DOIs | |
| State | Published - Aug 1 2011 |
Fingerprint
Keywords
- Atherosclerosis
- Biomarkers
- Cardiomyopathy
- Child
- Congenital heart disease
- Heart failure
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Pediatrics, Perinatology, and Child Health
Cite this
The promise of cardiovascular biomarkers in assessing children with cardiac disease and in predicting cardiovascular events in adults. / Wilkinson, James D.; Diamond, Melissa; Miller, Tracie L.
In: Progress in Pediatric Cardiology, Vol. 32, No. 1, 01.08.2011, p. 25-34.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The promise of cardiovascular biomarkers in assessing children with cardiac disease and in predicting cardiovascular events in adults
AU - Wilkinson, James D.
AU - Diamond, Melissa
AU - Miller, Tracie L
PY - 2011/8/1
Y1 - 2011/8/1
N2 - Cardiac and vascular biomarkers are used in the diagnosis, assessment, and prognosis of a variety of cardiovascular diseases in adults and children. For children, cardiac biomarkers are most often used to assess cardiomyopathy or congenital cardiovascular malformations or for monitoring during cardio-pulmonary bypass and pre- and post-heart transplantation. Because the risk for cardiovascular events in adulthood can be tracked from childhood, interest is high in identifying biomarkers of vascular inflammation in children that might also predict atherosclerotic events later in life. Here, we review the most common and promising biomarkers and comment on their current and potential uses in monitoring and predicting cardiovascular dysfunction.
AB - Cardiac and vascular biomarkers are used in the diagnosis, assessment, and prognosis of a variety of cardiovascular diseases in adults and children. For children, cardiac biomarkers are most often used to assess cardiomyopathy or congenital cardiovascular malformations or for monitoring during cardio-pulmonary bypass and pre- and post-heart transplantation. Because the risk for cardiovascular events in adulthood can be tracked from childhood, interest is high in identifying biomarkers of vascular inflammation in children that might also predict atherosclerotic events later in life. Here, we review the most common and promising biomarkers and comment on their current and potential uses in monitoring and predicting cardiovascular dysfunction.
KW - Atherosclerosis
KW - Biomarkers
KW - Cardiomyopathy
KW - Child
KW - Congenital heart disease
KW - Heart failure
UR - http://www.scopus.com/inward/record.url?scp=79961171435&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79961171435&partnerID=8YFLogxK
U2 - 10.1016/j.ppedcard.2011.06.006
DO - 10.1016/j.ppedcard.2011.06.006
M3 - Article
VL - 32
SP - 25
EP - 34
JO - Progress in Pediatric Cardiology
JF - Progress in Pediatric Cardiology
SN - 1058-9813
IS - 1
ER -